EA201692217A1 - POLYMORPHIC FORMS OF FURAZIDINE - Google Patents
POLYMORPHIC FORMS OF FURAZIDINEInfo
- Publication number
- EA201692217A1 EA201692217A1 EA201692217A EA201692217A EA201692217A1 EA 201692217 A1 EA201692217 A1 EA 201692217A1 EA 201692217 A EA201692217 A EA 201692217A EA 201692217 A EA201692217 A EA 201692217A EA 201692217 A1 EA201692217 A1 EA 201692217A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- furazidine
- polymorphic forms
- nitrofuran
- imidazolidin
- ylidene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Настоящее изобретение относится к кристаллическим формам фуразидина (1-{[(1Е,2Е)-3-(5-нитрофуран-2-ил)проп-2-ен-1-илиден]амино}имидазолидин-2,4-диона) и способам их получения.The present invention relates to crystalline forms of furazidine (1 - {[(1E, 2E) -3- (5-nitrofuran-2-yl) prop-2-en-1-ylidene] amino} imidazolidin-2,4-dione) and methods for their preparation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-14-44A LV15081B (en) | 2014-05-29 | 2014-05-29 | Polymorphs of furazidine |
PCT/IB2015/053968 WO2015181741A1 (en) | 2014-05-29 | 2015-05-27 | Polymorphic forms of furazidin |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201692217A1 true EA201692217A1 (en) | 2017-05-31 |
Family
ID=53969380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201692217A EA201692217A1 (en) | 2014-05-29 | 2015-05-27 | POLYMORPHIC FORMS OF FURAZIDINE |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3148988A1 (en) |
EA (1) | EA201692217A1 (en) |
LV (1) | LV15081B (en) |
MA (1) | MA39860A (en) |
UA (1) | UA115290C2 (en) |
WO (1) | WO2015181741A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990402A (en) | 1958-10-07 | 1961-06-27 | Smith Kline French Lab | Preparation of 1-aminohydantoin derivatives |
FR1489091A (en) * | 1966-05-09 | 1967-07-21 | Clin Byla Ets | New hydantoins and their preparation |
WO1997019930A1 (en) | 1995-11-27 | 1997-06-05 | Lonza Ag | Process for producing 1-aminohydantoin |
PL185120B1 (en) | 1997-03-17 | 2003-02-28 | Adamed Sp Z Oo | Method of obtaining 1-{[3-(5-nitro-2-furyl)-2-propenyliden]-amino}imidazolydin-2,4-dione |
-
2014
- 2014-05-29 LV LVP-14-44A patent/LV15081B/en unknown
-
2015
- 2015-05-27 MA MA039860A patent/MA39860A/en unknown
- 2015-05-27 UA UAA201611302A patent/UA115290C2/en unknown
- 2015-05-27 EP EP15753991.7A patent/EP3148988A1/en not_active Withdrawn
- 2015-05-27 EA EA201692217A patent/EA201692217A1/en unknown
- 2015-05-27 WO PCT/IB2015/053968 patent/WO2015181741A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
MA39860A (en) | 2015-12-03 |
WO2015181741A1 (en) | 2015-12-03 |
LV15081B (en) | 2016-11-20 |
EP3148988A1 (en) | 2017-04-05 |
UA115290C2 (en) | 2017-10-10 |
LV15081A (en) | 2015-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201790395A1 (en) | AMINOTRIAZIN DERIVATIVES SUITABLE FOR USING AS TANK-BINDING KINASE INHIBITORS | |
EA201891024A1 (en) | TANK-BINDING KINASE INHIBITOR COMPOUNDS | |
EA201792535A1 (en) | HETEROCYCLIC AMIDES AS KINAZ INHIBITORS | |
EA201691991A1 (en) | MULTI-SPECIFIC ANTIBODIES | |
EA201790984A1 (en) | ANTI-CD79B ANTIBODIES AND METHODS OF THEIR APPLICATION | |
EA201890247A1 (en) | DEZOXYURIDINTRIPHIPHPHATASI INHIBITORS CONTAINING HYDANTOIN | |
EA201591420A1 (en) | Heteroaryl Compounds and Their Use | |
EA201692203A1 (en) | TANK-BINDING KINAZ INHIBITING COMPOUNDS | |
DK3302448T3 (en) | SUBSTITUTED HETEROCYCLYL DERIVATIVES AS CDK INHIBITORS | |
EA201692338A1 (en) | COMPOUNDS OF 5-CHLOR-DIFTLOROMETOXYPHENYL-PYRAZOLOPIRIMIDINE, PRESENTING JANUS-KINASE INHIBITORS | |
EA201890899A1 (en) | PHARNESIDE X-RECEPTOR MODULATORS | |
EA201791117A1 (en) | PARTIAL AGONISTS INSULIN RECEPTOR | |
EA201790407A1 (en) | PROBES FOR VISUALIZATION PROTEIN HANTINGTIN | |
EA201691610A1 (en) | ANTI-JAGGED1 ANTIBODIES AND METHODS OF APPLICATION | |
EA201692425A1 (en) | MODIFIED BIOPOLYMERS AND METHODS OF THEIR PRODUCTION AND USE | |
EA201891251A1 (en) | PAD4 BICYCLIC INHIBITORS | |
EA201790892A1 (en) | CRYSTAL FORMS OF 5-CHLOR-N4- [2- (DIMETHYLPHOSPHORIL) PHENYL] -N2- {2-METHOXY-4- [4- (4-METHILPIPERAZIN-1-IL) PIPERIDIN-1-IL]} PYRIMIDIN-1-IL -DIAMINE | |
EA201891391A1 (en) | DIASTEREOCELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES AND HEMICITABIN PROTECTION NUC-1031 | |
EA201790982A1 (en) | SYNTHESIS OF KOPANLISIB AND ITS DIHYDROCHLORIDE | |
EA201790939A1 (en) | TRIAZOLO [4,5-d] Pyrimidine as an agonist of cannabinoid receptor type 2 | |
EA201592032A1 (en) | POLYMORPHIC FORMS OF NILOTINIB HYDROCHLORIDE | |
EA201692474A1 (en) | DERIVATIVES 1- (CYCLOPENT-2-EN-1-IL) -3- (2-HYDROXY-3- (ARYLSULFONIL) PHENYL) URECHEN AS CXCR2 Inhibitors | |
EA201790400A1 (en) | PROBES FOR VISUALIZATION PROTEIN HANTINGTIN | |
EA202091337A1 (en) | MYST FAMILY HISTONACETYLTRANSFERASE INHIBITORS | |
DK3670499T3 (en) | PYRAZOLE DERIVATIVES USE AS INHIBITORS OF 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) |